Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case‐control study within a screening setting

Emir Sehovic, Ilaria Gregnanin, Maurizia Mello‐Grand, Paola Ostano, Viviana Vergini, Andrea Ortale, Angela Amoruso, Elisabetta Favettini, Nereo Segnan, Giovanna Chiorino, Livia Giordano, Elisabetta Petracci

Open source

DOI
10.1002/ctm2.70068
Published
2024-11
Container
Clinical and Translational Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70068,
  title = {Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case‐control study within a screening setting},
  author = {Emir Sehovic and Ilaria Gregnanin and Maurizia Mello‐Grand and Paola Ostano and Viviana Vergini and Andrea Ortale and Angela Amoruso and Elisabetta Favettini and Nereo Segnan and Giovanna Chiorino and Livia Giordano and Elisabetta Petracci},
  year = {2024},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.70068},
  url = {https://doi.org/10.1002/ctm2.70068}
}

RIS

TY  - JOUR
TI  - Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case‐control study within a screening setting
AU  - Emir Sehovic
AU  - Ilaria Gregnanin
AU  - Maurizia Mello‐Grand
AU  - Paola Ostano
AU  - Viviana Vergini
AU  - Andrea Ortale
AU  - Angela Amoruso
AU  - Elisabetta Favettini
AU  - Nereo Segnan
AU  - Giovanna Chiorino
AU  - Livia Giordano
AU  - Elisabetta Petracci
PY  - 2024
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.70068
UR  - https://doi.org/10.1002/ctm2.70068
ER  - 

APA

Sehovic, E., Gregnanin, I., Mello‐Grand, M., Ostano, P., Vergini, V., Ortale, A., Amoruso, A., Favettini, E., Segnan, N., Chiorino, G., Giordano, L., & Petracci, E. (2024). Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case‐control study within a screening setting. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70068

Source records